Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis

Jaime D. Martinez,Alejandro Arboleda,Andrea Naranjo,Mariela C. Aguilar,Heather Durkee,Pedro Monsalve,Sander R. Dubovy,Kendall E. Donaldson,Darlene Miller,Guillermo Amescua,Jean-Marie Parel

American Journal of Ophthalmology Case Reports（2019）

引用 11|浏览17

暂无评分

摘要

Riboflavin PDAT can be used as an adjunct treatment in infectious keratitis to strengthen the corneal collagen fibers, delay keratolysis, and allow more time for antimicrobials to work and this way prevent a corneal perforation.

查看译文

关键词

Corneal infectious keratitis,Photodynamic antimicrobial therapy,Crosslinking,Riboflavin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要